Company Quick10K Filing
Stryker
10-Q 2020-06-30 Filed 2020-07-31
10-Q 2020-03-31 Filed 2020-05-01
10-K 2019-12-31 Filed 2020-02-06
10-Q 2019-09-30 Filed 2019-10-30
10-Q 2019-06-30 Filed 2019-07-26
10-Q 2019-03-31 Filed 2019-04-24
10-K 2018-12-31 Filed 2019-02-07
10-Q 2018-09-30 Filed 2018-10-26
10-Q 2018-06-30 Filed 2018-07-25
10-Q 2018-03-31 Filed 2018-04-27
10-K 2017-12-31 Filed 2018-02-08
10-Q 2017-09-30 Filed 2017-10-27
10-Q 2017-06-30 Filed 2017-07-28
10-Q 2017-03-31 Filed 2017-04-27
10-K 2016-12-31 Filed 2017-02-09
10-Q 2016-09-30 Filed 2016-10-28
10-Q 2016-06-30 Filed 2016-07-22
10-Q 2016-03-31 Filed 2016-04-22
10-K 2015-12-31 Filed 2016-02-11
10-Q 2015-09-30 Filed 2015-10-23
10-Q 2015-06-30 Filed 2015-07-29
10-Q 2015-03-31 Filed 2015-04-30
10-K 2014-12-31 Filed 2015-02-12
10-Q 2014-09-30 Filed 2014-10-23
10-Q 2014-06-30 Filed 2014-07-24
10-Q 2014-03-31 Filed 2014-04-24
10-K 2013-12-31 Filed 2014-02-13
10-Q 2013-09-30 Filed 2013-10-23
10-Q 2013-06-30 Filed 2013-07-23
10-Q 2013-03-31 Filed 2013-04-30
10-K 2012-12-31 Filed 2013-02-27
10-Q 2012-09-30 Filed 2012-10-22
10-Q 2012-06-30 Filed 2012-07-24
10-Q 2012-03-31 Filed 2012-04-24
10-K 2011-12-31 Filed 2012-02-13
10-Q 2011-09-30 Filed 2011-10-28
10-Q 2011-06-30 Filed 2011-07-28
10-Q 2011-03-31 Filed 2011-05-04
10-Q 2010-09-30 Filed 2010-11-04
10-Q 2010-06-30 Filed 2010-08-09
10-Q 2010-03-31 Filed 2010-04-29
10-K 2009-12-31 Filed 2010-02-26
8-K 2020-07-30 Earnings, Exhibits
8-K 2020-07-30 Regulation FD
8-K 2020-06-04
8-K 2020-05-26
8-K 2020-05-05
8-K 2020-04-30
8-K 2020-04-24
8-K 2020-03-31
8-K 2020-02-25
8-K 2020-01-28
8-K 2019-12-03
8-K 2019-11-29
8-K 2019-11-25
8-K 2019-11-04
8-K 2019-10-29
8-K 2019-07-31
8-K 2019-07-25
8-K 2019-05-07
8-K 2019-04-23
8-K 2019-03-25
8-K 2019-01-29
8-K 2018-11-27
8-K 2018-11-09
8-K 2018-10-25
8-K 2018-08-29
8-K 2018-07-31
8-K 2018-07-24
8-K 2018-07-10
8-K 2018-06-13
8-K 2018-05-04
8-K 2018-04-26
8-K 2018-04-03
8-K 2018-03-07
8-K 2018-02-26
8-K 2018-01-30
8-K 2018-01-09
8-K 2018-01-08

Stryker Financials

SYK Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
3M (MMM) 97,705 47% 14.9 12% 42,550 31,786 31,970 15,099 4,961 7,303 108,768
Stryker (SYK) 82,293 65% 20.6 13% 26,659 14,344 14,549 9,449 3,426 4,277 88,234
Becton Dickinson (BDX) 68,842 48% 21.2 2% 51,765 30,684 17,289 8,287 1,233 4,068 86,333
Boston Scientific (BSX) 56,926 71% 38.6 3% 26,756 7,831 5,566 704 1,706 65,840
Baxter (BAX) 45,469 42% 19.5 9% 17,544 9,708 11,080 4,667 1,582 2,185 42,544
ResMed (RMD) 19,678 59% 29.6 10% 4,155 2,037 2,699 1,599 419 701 20,719
Teleflex (TFX) 16,169 57% 32.5 7% 6,257 3,404 2,556 1,459 444 551 17,928
Dexcom (DXCM) 14,282 63% -153.6 -8% 2,186 1,421 1,351 845 -171 -90 13,886
Dentsply Sirona (XRAY) 11,909 52% 27.4 2% 8,367 3,308 3,977 2,079 162 477 13,086
Insulet (PODD) 10,214 66% 201.9 1% 1,268 1,118 694 457 17 53 10,780
ABIOMED (ABMD) 8,562 83% 28.3 20% 1,124 133 820 679 221 297 8,412
Novocure (NVCR) 7,902 73% -778.8 -6% 444 253 322 235 -27 -10 7,842
Hill-Rom Holdings (HRC) 7,085 49% 27.4 3% 4,919 3,346 2,907 1,425 152 298 8,166
Haemonetics (HAE) 6,479 47% 39.1 6% 1,191 607 988 465 68 172 6,738
Integra Lifesciences (IART) 5,281 63% 33.0 2% 3,347 1,962 1,506 944 60 181 5,962
Globus Medical (GMED) 5,230 77% 24.0 10% 1,452 113 770 592 146 211 5,063
Penumbra (PEN) 4,900 67% 90.7 7% 614 147 523 353 45 53 4,788
Nuvasive (NUVA) 3,895 72% 27.0 3% 1,840 1,146 831 48 161 4,347
Tandem Diabetes Care (TNDM) 3,612 53% -179.8 -8% 293 126 330 175 -24 -19 3,455
ICU Medical (ICUI) 3,368 38% 21.1 4% 1,638 297 1,291 492 73 144 3,031

Balance Sheet ($MM)2009-12-312010-03-312010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash6591,2027859261,7587354978109056901,3931,4231,3951,9139711,1101,3391,3811,3191,3561,7951,6743,6263,1633,3796,9763,4902,9533,3163,2133,6492,5922,5422,1791,6411,9183,6161,6741,7541,948
Accounts Receivable1,1471,1211,1081,1591,2521,3101,3481,3191,4171,4721,3681,3561,4301,4081,4131,3701,5181,4301,5031,5291,5721,5211,5001,4961,6621,5911,7581,8031,9671,8751,9051,9652,1982,1082,0892,0762,3322,2842,4082,438
Inventory9439619681,0351,0571,2201,2841,2971,2831,3181,2891,3151,2651,3231,3451,4041,4221,4981,5871,6661,5881,5821,6191,6651,6391,7681,9892,0922,0302,1722,2792,4542,4652,6642,7402,8932,9553,0643,1983,269
PP&E1,9649258999321,8508458868882,0552,1212,1002,1692,2322,2982,3452,4092,4972,5842,6262,6022,5972,5282,6042,6562,7302,8113,0703,1233,1613,3333,5183,6893,8003,9814,0364,1524,2774,3424,4784,603
Assets9,07110,09810,06010,77210,89511,23111,59612,08312,40512,45912,26212,77713,20614,08914,38214,88315,74316,15917,22917,51517,71316,58016,81915,91716,24719,66820,52020,18720,43520,51721,29221,48522,19722,13321,57022,08427,22925,93726,35426,659
Accounts Payable200231213248292292307282345311295270288297277278314350337335329333342340410394425420437456427458487529561563646619616659
Long-Term Debt9961,0151,0161,0221,0251,0211,7801,7681,7741,7501,7511,7462,7382,7422,7432,7392,2443,2373,2313,2463,2573,2422,5113,2536,7066,7176,7136,6867,1846,5926,5936,5905,9205,9255,9288,4867,9507,9747,889
Liabilities2,4763,4283,3153,4663,7223,7793,8184,5264,7224,4374,3104,4164,6095,6335,7796,1466,6967,0968,2278,8919,1188,2598,3147,4337,73610,86011,42210,85510,88510,81311,25711,06012,21712,91012,11012,22415,49914,24414,41114,344
Stockholders' Equity6,5956,6716,7467,3067,1747,4527,7787,5577,6838,0227,9528,3618,5978,4568,6038,7379,0479,0639,0028,6248,5958,3218,5058,4848,5118,8089,0989,3329,5509,70410,03510,4259,9669,2149,4609,86011,730
Income Statement ($MM)2009-12-312010-03-312010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue1,7991,7581,7681,9952,0152,2932,0312,2152,1612,1062,0522,3382,1902,2122,1512,4682,3052,3632,3892,6182,3792,4322,4202,7152,4952,8402,8333,1572,9553,0123,0063,4713,2413,3223,2423,7963,5163,6503,587
Cost of Revenue5815395416246898616697407096726557457136506828527698088228928268277968958019989601,0719931,0221,0241,2321,1041,1321,0871,3401,2331,2701,257
Gross Profit1,2181,2191,2271,3711,3261,4321,3621,4751,4521,4341,3971,5931,4771,5621,4691,6161,5361,5551,5671,7261,5531,6051,6241,8201,6941,8421,8732,0861,9621,9901,9822,2392,1372,1902,1552,4562,2832,3802,330
R&D909599111111127122115112116114129129132136139150158153153152154155164159183184189192192198205204216221225246246
SG&A6686626437347659087658348198777911,0339161,0151,1369991,2051,1489103128928618879709441,0431,0571,0931,1021,1301,1031,2171,2361,1901,2421,4031,2821,291
Tax12412412484104101104321181249188715634453739368201153944907953647855533789899171-566885115
Net Income3223193382953073093284013503253532703042131033867012857260224392301522402380355510444391434-2494434525902,068412480466
Cash Flow ($MM)2009-12-312010-03-312010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating27532742851820415644662735457569596236356622672206366535675380202-50967120346849364815165079679297649618313514629
Cash Investing-605-697-196702-878-380-497-380-123384-428-569-360-1,198-368-291-351-998-424-883262,650315-58557-3,969-102-177-146-192-815-460-849-224-156-303-247-186
Cash Financing898-15-124-349-389-21388-139-128-148-110-63651668-105-153186879-67-78-734-984-2511613,31824-939-42-137-40-345-272145-917-179-1,947-188-225